These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8448707)

  • 1. Tentative guidelines for using clinical and economic evaluations revisited.
    Laupacis A; Feeny D; Detsky AS; Tugwell PX
    CMAJ; 1993 Mar; 148(6):927-9. PubMed ID: 8448707
    [No Abstract]   [Full Text] [Related]  

  • 2. Technology assessment and cost-effectiveness analysis: misguided guidelines?
    Naylor CD; Williams JI; Basinski A; Goel V
    CMAJ; 1993 Mar; 148(6):921-4. PubMed ID: 8448706
    [No Abstract]   [Full Text] [Related]  

  • 3. Basic concepts and fundamental issues in technology assessment.
    Franklin C
    Intensive Care Med; 1993; 19(2):117-21. PubMed ID: 8486866
    [No Abstract]   [Full Text] [Related]  

  • 4. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.
    Laupacis A; Feeny D; Detsky AS; Tugwell PX
    CMAJ; 1992 Feb; 146(4):473-81. PubMed ID: 1306034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem.
    Gafni A; Birch S
    CMAJ; 1993 Mar; 148(6):913-7. PubMed ID: 8448705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EUR-ASSESS Project Subgroup report on Methodology. Methodological guidance for the conduct of health technology assessment.
    Liberati A; Sheldon TA; Banta HD
    Int J Technol Assess Health Care; 1997; 13(2):186-219. PubMed ID: 9194352
    [No Abstract]   [Full Text] [Related]  

  • 7. The importance of subjective values to medical technology assessment and health policy.
    Diamond GA
    J Invasive Cardiol; 1993; 5(1):17-22. PubMed ID: 10148297
    [No Abstract]   [Full Text] [Related]  

  • 8. Developing Guidance on Ethics for Patient Groups Collecting and Reporting Patient Information for Health Technology Assessments.
    Single AN; Scott AM; Wale J
    Patient; 2016 Feb; 9(1):1-4. PubMed ID: 26476960
    [No Abstract]   [Full Text] [Related]  

  • 9. Magnetic resonance imaging: in need of assessment.
    Vellet D
    Dimens Health Serv; 1991 Mar; 68(2):24-6. PubMed ID: 2029964
    [No Abstract]   [Full Text] [Related]  

  • 10. Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria.
    Evers S; Goossens M; de Vet H; van Tulder M; Ament A
    Int J Technol Assess Health Care; 2005; 21(2):240-5. PubMed ID: 15921065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of cost-effectiveness evaluations as part of national health technology assessments of biologic DMARDs in the treatment of rheumatoid arthritis.
    Iannazzo S; De Francesco M; Gomez-Ulloa D; Benucci M
    Expert Rev Pharmacoecon Outcomes Res; 2013 Aug; 13(4):455-68. PubMed ID: 23977974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some alternative perspectives concerning medical technology assessment.
    Diamond GA
    J Invasive Cardiol; 1992; 4(1):39-44. PubMed ID: 10149903
    [No Abstract]   [Full Text] [Related]  

  • 13. Increasing the generalizability of economic evaluations: recommendations for the design, analysis, and reporting of studies.
    Drummond M; Manca A; Sculpher M
    Int J Technol Assess Health Care; 2005; 21(2):165-71. PubMed ID: 15921055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is There a European View on Health Economic Evaluations? Results from a Synopsis of Methodological Guidelines Used in the EUnetHTA Partner Countries.
    ; Heintz E; Gerber-Grote A; Ghabri S; Hamers FF; Rupel VP; Slabe-Erker R; Davidson T
    Pharmacoeconomics; 2016 Jan; 34(1):59-76. PubMed ID: 26446858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From principle to public policy: using cost-effectiveness analysis.
    Neumann PJ; Johannesson M
    Health Aff (Millwood); 1994; 13(3):206-14. PubMed ID: 7927151
    [No Abstract]   [Full Text] [Related]  

  • 16. The science of health technology assessment--the economic perspective.
    Menon D
    Can J Clin Pharmacol; 2001; 8 Suppl A():17A-20A. PubMed ID: 11586373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Best practice in undertaking and reporting health technology assessments. Working group 4 report.
    Velasco M; Perleth M; Drummond M; Gürtner F; Jørgensen T; Jovell A; Malone J; Rüther A; Wild C
    Int J Technol Assess Health Care; 2002; 18(2):361-422. PubMed ID: 12053427
    [No Abstract]   [Full Text] [Related]  

  • 18. Health technology assessment and economic evaluation across jurisdictions.
    Simoens S
    Value Health; 2010; 13(6):857-9. PubMed ID: 20701730
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessing the quality of medical information technology economic evaluations: room for improvement.
    Eisenstein EL; Ortiz M; Anstrom KJ; Crosslin DR; Lobach DF
    AMIA Annu Symp Proc; 2006; 2006():234-8. PubMed ID: 17238338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardizing economic appraisal of health technology in the European Community.
    Rovira J
    Soc Sci Med; 1994 Jun; 38(12):1675-8. PubMed ID: 8047926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.